Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia - PubMed (original) (raw)

Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia

I P Everall et al. Acta Neuropathol. 1994.

Abstract

Human immune deficiency virus (HIV) disease may be associated, neuropathologically, with significant neuronal loss and clinically with a severe dementia. However, the significance of neuronal loss in the development of dementia has not been established. In this study we have undertaken a stereological determination of the neuronal numerical density and neuronal volumes in post mortem tissue from the superior frontal and superior temporal gyri in 32 patients who died of acquired immune deficiency syndrome (AIDS). All were prospectively clinically characterized, with dementia identified or excluded, and antiretroviral medication documented. This study combines morphometric techniques with prospective clinical assessment of dementia. As previously demonstrated, all patients dying with AIDS showed neuronal loss, but this was not related to the presence of HIV-associated dementia.

PubMed Disclaimer

Similar articles

• Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.
  Glass JD, Fedor H, Wesselingh SL, McArthur JC. Glass JD, et al. Ann Neurol. 1995 Nov;38(5):755-62. doi: 10.1002/ana.410380510. Ann Neurol. 1995. PMID: 7486867
• A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia.
  Everall I, Luthert P, Lantos P. Everall I, et al. J Neuropathol Exp Neurol. 1993 Nov;52(6):561-6. doi: 10.1097/00005072-199311000-00002. J Neuropathol Exp Neurol. 1993. PMID: 8229074 Review.
• Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.
  Cairns NJ, Brännström T, Khan MN, Rossor MN, Lantos PL. Cairns NJ, et al. Exp Neurol. 2003 Jun;181(2):319-26. doi: 10.1016/s0014-4886(03)00095-5. Exp Neurol. 2003. PMID: 12782004
• Neuronal damage and its relation to dementia in acquired immunodeficiency syndrome (AIDS).
  Trillo-Pazos G, Everall IP. Trillo-Pazos G, et al. Pathobiology. 1996;64(6):295-307. doi: 10.1159/000164064. Pathobiology. 1996. PMID: 9159023 Review.

Cited by

• Apoptosis induced by HIV-1 infection of the central nervous system.
  Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, Gabuzda D. Shi B, et al. J Clin Invest. 1996 Nov 1;98(9):1979-90. doi: 10.1172/JCI119002. J Clin Invest. 1996. PMID: 8903316 Free PMC article.
• Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.
  Bellizzi MJ, Lu SM, Gelbard HA. Bellizzi MJ, et al. J Neuroimmune Pharmacol. 2006 Mar;1(1):20-31. doi: 10.1007/s11481-005-9006-y. J Neuroimmune Pharmacol. 2006. PMID: 18040788 Review.
• Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
  Green AJ, Giovannoni G, Hall-Craggs MA, Thompson EJ, Miller RF. Green AJ, et al. Sex Transm Infect. 2000 Dec;76(6):443-6. doi: 10.1136/sti.76.6.443. Sex Transm Infect. 2000. PMID: 11221126 Free PMC article.
• CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy.
  Zhu Y, Vergote D, Pardo C, Noorbakhsh F, McArthur JC, Hollenberg MD, Overall CM, Power C. Zhu Y, et al. FASEB J. 2009 Sep;23(9):2928-41. doi: 10.1096/fj.08-128819. Epub 2009 Apr 20. FASEB J. 2009. PMID: 19380511 Free PMC article.

References

1. 1. Lab Invest. 1992 Mar;66(3):285-91 - PubMed
2. 1. Lancet. 1987 Jan 17;1(8525):132-5 - PubMed
3. 1. Ann Neurol. 1986 Jun;19(6):517-24 - PubMed
4. 1. Ann Neurol. 1992 Apr;31(4):349-60 - PubMed
5. 1. Acta Neuropathol. 1993;85(2):185-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program